Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,877 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Search for the Majorana Nature of Neutrinos in the Inverted Mass Ordering Region with KamLAND-Zen.
Abe S, Asami S, Eizuka M, Futagi S, Gando A, Gando Y, Gima T, Goto A, Hachiya T, Hata K, Hayashida S, Hosokawa K, Ichimura K, Ieki S, Ikeda H, Inoue K, Ishidoshiro K, Kamei Y, Kawada N, Kishimoto Y, Koga M, Kurasawa M, Maemura N, Mitsui T, Miyake H, Nakahata T, Nakamura K, Nakamura K, Nakamura R, Ozaki H, Sakai T, Sambonsugi H, Shimizu I, Shirai J, Shiraishi K, Suzuki A, Suzuki Y, Takeuchi A, Tamae K, Ueshima K, Watanabe H, Yoshida Y, Obara S, Ichikawa AK, Chernyak D, Kozlov A, Nakamura KZ, Yoshida S, Takemoto Y, Umehara S, Fushimi K, Kotera K, Urano Y, Berger BE, Fujikawa BK, Learned JG, Maricic J, Axani SN, Smolsky J, Fu Z, Winslow LA, Efremenko Y, Karwowski HJ, Markoff DM, Tornow W, Dell'Oro S, O'Donnell T, Detwiler JA, Enomoto S, Decowski MP, Grant C, Li A, Song H; KamLAND-Zen Collaboration. Abe S, et al. Among authors: inoue k. Phys Rev Lett. 2023 Feb 3;130(5):051801. doi: 10.1103/PhysRevLett.130.051801. Phys Rev Lett. 2023. PMID: 36800472
Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.
Miyake M, Nishimura N, Oda Y, Miyamoto T, Iida K, Inoue K, Tachibana A, Yoshikawa T, Sakamoto K, Ohnishi M, Maesaka F, Takamatsu N, Mieda K, Ohmori C, Matsubara T, Tomizawa M, Shimizu T, Ohnishi K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K; Nara Urological Research and Treatment Group. Miyake M, et al. Among authors: inoue k. Int J Clin Oncol. 2024 Jun 18. doi: 10.1007/s10147-024-02573-5. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38888683
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN).
Kato T, Matsumoto R, Yokomizo A, Tohi Y, Fukuhara H, Fujii Y, Mori K, Sato T, Inokuchi J, Hashine K, Sakamoto S, Kinoshita H, Inoue K, Tanikawa T, Utsumi T, Goto T, Hara I, Okuno H, Kakehi Y, Sugimoto M. Kato T, et al. Among authors: inoue k. BJU Int. 2024 Jun 17. doi: 10.1111/bju.16436. Online ahead of print. BJU Int. 2024. PMID: 38886979
9,877 results